Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk - rasagiline - tablet - 1mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord healthcare ltd - rasagiline - tablet - 1mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

rivopharm (uk - rasagiline - tablet - 1mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - rasagiline - tablet - 1mg

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: purified talc; maize starch; citric acid monohydrate; microcrystalline cellulose; stearic acid; colloidal anhydrous silica; pregelatinised maize starch - rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: citric acid monohydrate; colloidal anhydrous silica; stearic acid; purified talc; pregelatinised maize starch; microcrystalline cellulose; maize starch - rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - rasagiline mesylate 1,56 mg - eq. rasagiline 1 mg - tablet - rasagiline

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: stearic acid; purified talc; mannitol; colloidal anhydrous silica; maize starch; pregelatinised maize starch - azilect is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: citric acid monohydrate; pregelatinised maize starch; purified talc; colloidal anhydrous silica; microcrystalline cellulose; stearic acid; maize starch - rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

Malta - Ingliż - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - rasagiline - tablet - rasagiline 1 mg - anti-parkinson drugs